Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE

Area of Science:

• Oncology
• Cell Biology
• Proteomics

Background:

• Cancer develops through accumulated genetic alterations.
• Studying tumorigenesis in experimental models circumvents patient genetic heterogeneity.
• Identifying critical genetic changes is vital for developing targeted anti-cancer drugs.

Purpose of the Study:

• To analyze protein level changes during stepwise malignant transformation of human fibroblasts.
• To identify specific proteins regulated during tumorigenesis.
• To correlate proteomic alterations with defined stages of cancer development.

Main Methods:

• Utilized a cell culture model of malignant transformation using BJ strain human fibroblasts.
• Sequentially transduced fibroblasts with genes for hTERT, SV40 early region (SV40 ER), and H-Ras V12.
• Performed differential proteome analysis (2D-PAGE) to identify regulated proteins.
• Confirmed results for some protein candidates using Western Blot.

Main Results:

• Identified 39 regulated protein spots containing 67 different proteins during malignant transformation.
• Observed the strongest spot pattern changes upon integration of SV40 ER.
• Found significant regulation of proliferating cell nuclear antigen (PCNA), TRAP-1, and HSP90.
• Noted upregulation of TRAP-1 by SV40 ER expression, preceding H-Ras V12.
• Identified regulation of Peroxiredoxin-6 (PRDX6), Annexin A2, PAI-2, and Keratin 7.

Conclusions:

• Findings suggest interactions between the p16-RB pathway, mitochondrial chaperones, and the cytoskeleton.
• The cell culture model effectively relates proteomic and cellular changes to specific tumorigenesis steps.
• This research provides insights into molecular mechanisms driving malignant transformation.